Neratinib plus trastuzumab plus fulvestrant shows encouraging clinical activity Presented ByDr Komal Jhaveri, Memorial Sloan Kettering Cancer Center, NY, USA TrialPhase 2, SUMMIT ConferenceSABCS 2021 TypePeer-reviewed article 31 January 2022 17:37
SABCS 2021 Highlights Podcast Presented ByDr Rachel Giles, Medicom ConferenceSABCS 2021 10 January 2022 20:59